Live Breaking News & Updates on National Treatment Protocol

Stay updated with breaking news from National treatment protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

India To Import 4,50,000 Vials Of Anti-Viral Drug Remdesivir: Centre Amid Shortage


India To Import 4,50,000 Vials Of Anti-Viral Drug Remdesivir: Centre Amid Shortage
India To Import 4,50,000 Vials Of Anti-Viral Drug Remdesivir: Centre Amid Shortage
The government has ramped up the production capacity of Remdesivir in the country, the Union Ministry of Chemicals and Fertilisers said.
Advisory was issued to states, union territories to facilitate smooth movement of Remdesivir, Centre said
New Delhi:
The government of India has started importing anti-viral drug Remdesivir from other countries and the first consignment of 75,000 vials will reach India today amid the ongoing coronavirus pandemic, Union Ministry of Chemicals and Fertilisers has said.
The ministry stated that HLL Lifecare Ltd, a government of India-owned company has ordered 4,50,000 vials of Remdesivir from US pharma firm Gilead Sciences and Egyptian Pharma Company Eva Pharma. ....

National Pharmaceutical Pricing Authority , Gilead Sciences , Lifecare Ltd , National Treatment Protocol , Department Of Revenue , Union Ministry Of Chemicals , National Task Force Joint Monitoring , Centre Amid Shortage Advisory , Egyptian Pharma Company Eva , India To Import , Antiviral Drug Remdesivir , Centre Amid Shortage , Union Ministry , Treatment Protocol , Joint Monitoring , General News , Remdesivir Import , India Coronavirus , Teva Pharma , தேசிய மருந்து ப்ரைஸிஂக் அதிகாரம் , கிலியட் அறிவியல் , ஆயுட்காலம் லிமிடெட் , தேசிய சிகிச்சை ப்ரோடொகால் , துறை ஆஃப் வருவாய் , தொழிற்சங்கம் அமைச்சகம் ஆஃப் இரசாயனங்கள் , தொழிற்சங்கம் அமைச்சகம் ,

COVID-19: India to import 4,50,000 vials of Remdesivir, informs Centre


COVID-19: India to import 4,50,000 vials of Remdesivir, informs Centre
ANI |
Updated: Apr 30, 2021 12:45 IST
New Delhi [India], April 30 (ANI): The government of India has started importing Remdesivir from other countries and the first consignment of 75000 vials will reach India on Friday amid the ongoing COVID-19 pandemic, union ministry of chemicals and fertilizers has said.
The ministry stated that HLL Lifecare Ltd, a government of India-owned company has ordered 4,50,000 vials of Remdesivir from M/s Gilead Sciences Inc USA and Egyptian Pharma Company, M/s Eva Pharma.
It is expected that Gilead Sciences Inc. USA will dispatch 75,000 to 1,00,00 vials in the next one or two days. Further one hundred thousand quantities will also be supplied before or by May 15. EVA pharma will supply approximately 10,000 vials initially followed by 50,000 vials every 15 days or till July, said the ministry. ....

United States , New Delhi , Teva Pharma , Egyptian Pharma Company , Lifecare Ltd , National Treatment Protocol , Gilead Sciences Inc , Gilead Sciences Inc United States , Department Of Revenue , National Task Force Joint Monitoring , Gilead Sciences , Treatment Protocol , Joint Monitoring , ஒன்றுபட்டது மாநிலங்களில் , புதியது டெல்ஹி , ஈவா பார்மா , ஆயுட்காலம் லிமிடெட் , தேசிய சிகிச்சை ப்ரோடொகால் , கிலியட் அறிவியல் இன்க் , கிலியட் அறிவியல் இன்க் ஒன்றுபட்டது மாநிலங்களில் , துறை ஆஃப் வருவாய் , கிலியட் அறிவியல் , சிகிச்சை ப்ரோடொகால் , கூட்டு கண்காணிப்பு ,

COVID-19: India to import 4,50,000 vials of Remdesivir from other countries, informs govt


COVID-19: India to import 4,50,000 vials of Remdesivir from other countries, informs govt
File Photo
New Delhi: The government of India has started importing Remdesivir from other countries and the first consignment of 75000 vials will reach India on Friday amid the ongoing COVID-19 pandemic, union ministry of chemicals and fertilizers has said.
The ministry stated that HLL Lifecare Ltd, a government of India-owned company has ordered 4,50,000 vials of Remdesivir from M/s Gilead Sciences Inc USA and Egyptian Pharma Company, M/s Eva Pharma.
It is expected that Gilead Sciences Inc. USA will dispatch 75,000 to 1,00,00 vials in the next one or two days. Further one hundred thousand quantities will also be supplied before or by May 15. EVA pharma will supply approximately 10,000 vials initially followed by 50,000 vials every 15 days or till July, said the ministry. ....

Department Of Revenue , National Task Force Joint Monitoring , National Treatment Protocol , Treatment Protocol , Joint Monitoring , துறை ஆஃப் வருவாய் , தேசிய சிகிச்சை ப்ரோடொகால் , சிகிச்சை ப்ரோடொகால் , கூட்டு கண்காணிப்பு ,

'Taking oxygen intermittently does not help COVID patients': Experts on COVID treatment


Taking oxygen intermittently does not help COVID patients : Experts on COVID treatment
AIIMS Director Dr Randeep Guleria said more than 85 per cent of the COVID patients will recover without any specific treatment in the form of Remdesivir etc.
Share Via Email
  |  A+A A-
People carry empty 0xygen cylinders for free refilling provided by Residence Welfare Association (RWA) of Turkman Gate, as COVID-19 case spike in New Delhi. (Photo | PTI)
By PTI
NEW DELHI: Stating that oxygen is like a drug and taking it intermittently does not help, top doctors in the country highlighted on Wednesday that there is no data that shows that this will be of any assistance to COVID-19 patients and is, therefore, ill-advised. ....

Randeep Guleria , Naresh Trehan , Devi Shetty , Narayana Health , National Treatment Protocol , Medanta Hospital , Corona Virus , Covid 19 , ரந்தீப் குலேரியா , னரேஷ் திர்ேன் , தேவி ஷெட்டி , நாராயணா ஆரோக்கியம் , தேசிய சிகிச்சை ப்ரோடொகால் , மேதாண்த மருத்துவமனை , கொரோனா வைரஸ் ,